[Current treatment of tetanus patients in intensive therapy].
A brief survey of recent criteria for evaluation of the seriousness of toxicity and infection in tetanus is followed by the examination of a series of cases of average severity. The method employed in their therapeutic management is described, and an account is given of its advantages and the possibility of complications. The mortality rate for the years 1974-1978 is also reported.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D008875:Middle Aged; D010288:Parenteral Nutrition; D012121:Respiration, Artificial; D013565:Sympatholytics / Q000627:therapeutic use; D013742:Tetanus / Q000628:therapy*; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014611:Vaccination; D014882:Water-Electrolyte Balance
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002800:Cholinesterase Inhibitors; D006993:Hypnotics and Sedatives; D007136:Immunoglobulins; D013565:Sympatholytics; D013745:Tetanus Toxoid
Trattamento attuale del tetano in terapia intensiva.